ArticlePharmaceuticals (Basel, Switzerland)2022

The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients.

Sahar H Elhini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.